AFINION HBA1C DX
Device
Abbott Laboratories
Total Payments
$84,481
Transactions
67
Doctors
11
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $4,766 | 8 | 7 |
| 2023 | $2,625 | 5 | 3 |
| 2022 | $77,091 | 54 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $77,021 | 51 | 91.2% |
| Consulting Fee | $4,000 | 7 | 4.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,088 | 2 | 3.7% |
| Food and Beverage | $373.07 | 7 | 0.4% |
Payments by Type
Research
$77,021
51 transactions
General
$7,461
16 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes | Abbott Laboratories | $77,021 | 0 |
Top Doctors Receiving Payments for AFINION HBA1C DX
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Renton, WA | $77,171 | 52 |
| , M.D | Family Medicine | San Antonio, TX | $4,388 | 3 |
| , M.D | Internal Medicine | Stockton, CA | $1,000 | 1 |
| , DO | Family Medicine | Vallejo, CA | $875.00 | 2 |
| , MD | Endocrinology, Diabetes & Metabolism | New Orleans, LA | $675.00 | 2 |
| , M.D | Family Medicine | Jenkintown, PA | $75.80 | 1 |
| , M.D | Specialist | Escondido, CA | $75.80 | 1 |
| , M.D | Family Medicine | Winnsboro, SC | $75.80 | 1 |
| , D.O | Obesity Medicine | Bend, OR | $75.80 | 1 |
| , MD | Family Medicine | Austell, GA | $23.69 | 1 |
| , M.D | Endocrinology, Diabetes & Metabolism | Atlanta, GA | $23.09 | 1 |
| , MD | Internal Medicine | Atlanta, GA | $23.09 | 1 |
Ad
Manufacturing Companies
- Abbott Laboratories $84,481
Product Information
- Type Device
- Total Payments $84,481
- Total Doctors 11
- Transactions 67
About AFINION HBA1C DX
AFINION HBA1C DX is a device associated with $84,481 in payments to 11 healthcare providers, recorded across 67 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2022 to 2024. In 2024, $4,766 was paid across 8 transactions to 7 doctors.
The most common payment nature for AFINION HBA1C DX is "Unspecified" ($77,021, 91.2% of total).
AFINION HBA1C DX is associated with 1 research study, including "Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes" ($77,021).